Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $6.24 billion. The enterprise value is $9.42 billion.
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025, after market close.
Earnings Date | Apr 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 60.73 million shares outstanding. The number of shares has decreased by -8.41% in one year.
Current Share Class | 60.73M |
Shares Outstanding | 60.73M |
Shares Change (YoY) | -8.41% |
Shares Change (QoQ) | -2.65% |
Owned by Insiders (%) | 2.92% |
Owned by Institutions (%) | 99.53% |
Float | 58.90M |
Valuation Ratios
The trailing PE ratio is 11.88 and the forward PE ratio is 4.41. JAZZ's PEG ratio is 0.46.
PE Ratio | 11.88 |
Forward PE | 4.41 |
PS Ratio | 1.56 |
Forward PS | 1.43 |
PB Ratio | 1.52 |
P/TBV Ratio | n/a |
P/FCF Ratio | 4.60 |
P/OCF Ratio | 4.47 |
PEG Ratio | 0.46 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 6.19, with an EV/FCF ratio of 6.93.
EV / Earnings | 16.81 |
EV / Sales | 2.31 |
EV / EBITDA | 6.19 |
EV / EBIT | 10.93 |
EV / FCF | 6.93 |
Financial Position
The company has a current ratio of 4.46, with a Debt / Equity ratio of 1.51.
Current Ratio | 4.46 |
Quick Ratio | 3.57 |
Debt / Equity | 1.51 |
Debt / EBITDA | 3.97 |
Debt / FCF | 4.54 |
Interest Coverage | 2.50 |
Financial Efficiency
Return on equity (ROE) is 14.31% and return on invested capital (ROIC) is 5.44%.
Return on Equity (ROE) | 14.31% |
Return on Assets (ROA) | 4.60% |
Return on Invested Capital (ROIC) | 5.44% |
Return on Capital Employed (ROCE) | 7.85% |
Revenue Per Employee | $1.45M |
Profits Per Employee | $200,043 |
Employee Count | 2,800 |
Asset Turnover | 0.35 |
Inventory Turnover | 0.58 |
Taxes
Income Tax | -91.43M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.32% in the last 52 weeks. The beta is 0.42, so JAZZ's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | -6.32% |
50-Day Moving Average | 128.48 |
200-Day Moving Average | 118.46 |
Relative Strength Index (RSI) | 31.87 |
Average Volume (20 Days) | 1,619,122 |
Short Selling Information
The latest short interest is 4.28 million, so 7.05% of the outstanding shares have been sold short.
Short Interest | 4.28M |
Short Previous Month | 4.52M |
Short % of Shares Out | 7.05% |
Short % of Float | 7.27% |
Short Ratio (days to cover) | 3.34 |
Income Statement
In the last 12 months, JAZZ had revenue of $4.07 billion and earned $560.12 million in profits. Earnings per share was $8.65.
Revenue | 4.07B |
Gross Profit | 3.76B |
Operating Income | 861.64M |
Pretax Income | n/a |
Net Income | 560.12M |
EBITDA | 1.52B |
EBIT | 861.64M |
Earnings Per Share (EPS) | $8.65 |
Full Income Statement Balance Sheet
The company has $2.99 billion in cash and $6.17 billion in debt, giving a net cash position of -$3.17 billion or -$52.25 per share.
Cash & Cash Equivalents | 2.99B |
Total Debt | 6.17B |
Net Cash | -3.17B |
Net Cash Per Share | -$52.25 |
Equity (Book Value) | 4.09B |
Book Value Per Share | 67.52 |
Working Capital | 3.59B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $1.40 billion and capital expenditures -$38.07 million, giving a free cash flow of $1.36 billion.
Operating Cash Flow | 1.40B |
Capital Expenditures | -38.07M |
Free Cash Flow | 1.36B |
FCF Per Share | $22.36 |
Full Cash Flow Statement Margins
Gross margin is 92.36%, with operating and profit margins of 21.18% and 13.77%.
Gross Margin | 92.36% |
Operating Margin | 21.18% |
Pretax Margin | 11.52% |
Profit Margin | 13.77% |
EBITDA Margin | 37.40% |
EBIT Margin | 21.18% |
FCF Margin | 33.37% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 8.41% |
Shareholder Yield | n/a |
Earnings Yield | 8.97% |
FCF Yield | 21.75% |
Dividend Details Analyst Forecast
The average price target for JAZZ is $187.15, which is 83.44% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $187.15 |
Price Target Difference | 83.44% |
Analyst Consensus | Strong Buy |
Analyst Count | 13 |
Revenue Growth Forecast (5Y) | 5.59% |
EPS Growth Forecast (5Y) | 26.60% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.61 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.61 |
Piotroski F-Score | 6 |